Prestige Consumer Healthcare, Inc. (PBH)
52.02
+0.71
(+1.38%)
USD |
NYSE |
Aug 24, 16:00
52.44
+0.42
(+0.81%)
Pre-Market: 05:56
Prestige Consumer Healthcare Total Return Level : 52.02 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 52.02 |
| August 21, 2026 | 51.31 |
| August 20, 2026 | 50.52 |
| August 19, 2026 | 51.68 |
| August 18, 2026 | 50.57 |
| August 17, 2026 | 50.04 |
| August 14, 2026 | 51.38 |
| August 13, 2026 | 51.32 |
| August 12, 2026 | 52.27 |
| August 11, 2026 | 53.60 |
| August 10, 2026 | 53.00 |
| August 07, 2026 | 54.85 |
| August 06, 2026 | 54.43 |
| August 05, 2026 | 52.98 |
| August 04, 2026 | 52.00 |
| August 03, 2026 | 51.92 |
| July 31, 2026 | 50.22 |
| July 30, 2026 | 49.95 |
| July 29, 2026 | 52.19 |
| July 28, 2026 | 51.72 |
| July 27, 2026 | 50.40 |
| July 24, 2026 | 49.66 |
| July 23, 2026 | 48.94 |
| July 22, 2026 | 49.02 |
| July 21, 2026 | 49.03 |
| Date | Value |
|---|---|
| July 20, 2026 | 50.41 |
| July 17, 2026 | 49.92 |
| July 16, 2026 | 50.60 |
| July 15, 2026 | 48.36 |
| July 14, 2026 | 47.19 |
| July 13, 2026 | 48.83 |
| July 10, 2026 | 48.90 |
| July 09, 2026 | 48.48 |
| July 08, 2026 | 48.29 |
| July 07, 2026 | 50.42 |
| July 06, 2026 | 48.86 |
| July 02, 2026 | 49.42 |
| July 01, 2026 | 48.16 |
| June 30, 2026 | 47.27 |
| June 29, 2026 | 48.03 |
| June 26, 2026 | 49.41 |
| June 25, 2026 | 47.18 |
| June 24, 2026 | 47.32 |
| June 23, 2026 | 46.05 |
| June 22, 2026 | 45.46 |
| June 18, 2026 | 46.97 |
| June 17, 2026 | 46.14 |
| June 16, 2026 | 47.50 |
| June 15, 2026 | 46.67 |
| June 12, 2026 | 47.82 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Indivior Pharmaceuticals, Inc. | 37.63 |
| ANI Pharmaceuticals, Inc. | 74.17 |
| Corcept Therapeutics, Inc. | 123.24 |
| Veru, Inc. | 3.028 |
| Johnson & Johnson | 648.35 |